Background: Prenatal environment has been shown to influence child's risk of ato-
Sakari Sohlberg Foundation, The Finnish Medical Foundation and Finnish Cultural Foundation. during pregnancy, and mother's seropositivity against human cytomegalovirus (CMV) and Helicobacter pylori.
Results:
Maternal EV infection during pregnancy was inversely associated with atopic outcome in the offspring (odds ratio 0.43; 95% confidence interval: 0.23-0.80, P = 0.008). Acute IAV or M. pneumoniae infections or seropositivity against CMV or Helicobacter pylori were not associated with the atopic outcome.
Conclusions and Clinical Relevance:
Our results suggest that maternal EV infections during pregnancy are inversely associated with atopic disease in the offspring. Our finding provides further support to the previous studies suggesting an important role of the in utero environment in the development of atopic diseases.
| INTRODUCTION
Genetic factors regulate the susceptibility to atopic diseases but the environment has a significant impact on the disease development.
Atopic diseases usually manifest in childhood stressing the importance of environmental factors present in very early life. 1 Accordingly, extensive data suggest that a variety of environmental exposures in early childhood can influence the development of atopic diseases. 2 Postnatal microbial infections have been among the most studied factors and several reports have suggested a modulation of the risk of atopic diseases by childhood infections. [3] [4] [5] [6] [7] [8] [9] [10] [11] Recently, it has become increasingly evident that already the in utero environment may be important in the development of atopic diseases. 2 A number of prenatal factors, for example, maternal smoking, 12 adverse life events 13 and pre-pregnancy overweight 14 have been associated with increased risk of atopic diseases in the offspring. In contrast, maternal exposure to farming environment has been shown to protect the child from atopy. [15] [16] [17] These findings, consistent with the framework of hygiene hypothesis, raise the question about the role of prenatal microbial infections in atopy.
The majority of previous data on prenatal infections are derived from questionnaire-based studies, most of which report an increased risk of atopic disease in children born to mothers with febrile or flu-like infections during pregnancy. 18 However, questionnaire-based studies do not enable the identification of culprit microbes and they may be affected by recall bias. Applying laboratory assay-based methods can overcome these shortcomings but such studies are scarce. [19] [20] [21] [22] Maternal gastrointestinal helminth infections have been reported both to inversely associate with eczema in the offspring 20 and not to associate with atopy. 19 Intrauterine bacterial growth at birth as well as chorioamnionitis has been shown to increase the risk of asthma in the offspring. 21, 23 We wanted to investigate whether laboratory-confirmed prenatal infections are associated with atopic outcome in the offspring. In addition, we aimed to determine whether microbes with different infectious and immunological reaction patterns differ in their effect.
Five microbes, featuring gastrointestinal and respiratory pathogens, as well as microbes causing acute and chronic infections were included in the current study.
Enteroviruses (EV) can replicate in the gastrointestinal tract, and they have been linked to atopy in some studies [6] [7] [8] but not all. 4 
| MATERIALS AND METHODS

| Subjects
The study cohort was derived from the prospective Type 1 Diabetes Prediction and Prevention (DIPP) study in Finland. 25 In the DIPP 
| IgE antibodies
IgE antibodies against a mixture of common aeroallergens were analysed from the serum samples taken at the age of 5 years with
ImmunoCAP® enzyme immunoassay (Phadia AB, Uppsala, Sweden).
The multi-allergen test used (Phadiatop®, Phadia AB, Uppsala, Sweden) contains allergens of common pollens, moulds and animals.
Values of ≥0.35 kU/L were considered positive.
| Microbial analyses
IgG class antibodies against EV, IAV, H. pylori and M. pneumoniae were measured by applying enzyme immune assays (EIA). IgG class antibodies against CMV were measured either by applying EIA or by chemiluminescent immunoassay (CLIA). For CMV, two different assays were used due to changes in laboratory equipment during the study period but each case-control pair was always analysed with the same method.
Enterovirus, IAV and M. pneumoniae antibodies were analysed from both first trimester serum samples and cord blood, H. pylori antibodies from cord blood and CMV antibodies from first trimester serum samples (n = 146) or cord blood (n = 381), whichever was available. Samples from case-control pairs and related first trimester and cord blood samples were analysed in parallel in the same test run. All analyses were carried out blind to clinical information.
The assay for EV antibodies employed a synthetic EV peptide that carries an immunodominant epitope of the viral VP1 protein (sequence KEVPALTAVETGAT-C) as an antigen, as described. 26 This epitope is highly conserved among EVs detecting antibodies against a wide range of different EV types. For IAV, we used influenza A virus strain Beijing (BA1231VS, Virion Serion, Würzburg, Germany)
as an antigen, as previously described. 27 In brief, microtiter plates (Nunc Immuno ™ plate, Maxisorb, Thermo Fisher Scientific, Waltham, MA, USA) were coated by the antigens at concentrations 1 μg/mL for EV and 3 μg/mL for IAV in carbonate buffer (pH 9. 
| Definition of acute infection
According to the manufacturer's instructions, we defined an acute M. pneumoniae infection as a 1.6-fold or higher increase in antibody level between the maternal first trimester sample and the child's cord blood sample. For cohesion, we applied the same criteria also for EV and IAV to indicate an acute infection during pregnancy.
| Statistical methods
We applied conditional logistic regression analysis to determine the association between an acute infection during pregnancy (EV, IAV, M. pneumoniae) or seropositivity (CMV, H. pylori) and atopic disease.
The results are presented as odds ratios (OR) and 95% confidence intervals (CI) for atopic disease.
Demographic factors are presented in Table 1 . We applied conditional regression analysis to estimate the individual association of each variable with atopic outcome. When an association was observed, conditional regression analysis was applied to adjust for these factors. If a value was missing from the case child or all controls in the case-control group, that case-control pair/triplet was excluded from the analyses.
We applied the Bonferroni correction to counteract the problem of multiple comparisons. As we analysed the association between acute infection during pregnancy and atopic disease for three microbes, the Bonferroni correction to control type I error was justi- 
| RESULTS
Out of the 202 case children, 52 (26%) had asthma, 126 (62%) had atopic eczema and/or allergic rhinitis, and 24 (12%) had both asthma and eczema/rhinitis. Specific IgE values varied between 0.36 and 101 kU/L (mean 22.9, median 11). Demographics and their associations with atopic outcome are presented in Table 1 . 
| DISCUSSION
The current study suggests that maternal EV infections during pregnancy are inversely associated with atopic disease in the offspring.
To our knowledge, EVs or other microbes included have not been studied in a similar laboratory-based study setting previously.
We did not find any association between prenatal IAV and M. pneumoniae infections and atopic outcome. One reason may lie in the route of infection; IAV and M. pneumoniae are respiratory microbes, whereas EVs can replicate also in the gut. There are indications that exposures to enteric pathogens might be particularly important in the development of atopy and they have been reported to inversely associate with atopy in some studies 28, 29 but not in all. 3, 11 Our group has previously observed an inverse association between neutralizing antibodies against echoviruses, belonging to the enterovirus genus, and atopy. 6, 7 A recent study showed reduced anti-echovirus 30 antibody titres in asthmatic children as compared with non-asthmatics, 8 which was contrary to a previous rhinovirus antibody finding. 9 In addition, some EVs replicate for relatively long periods in the gut-associated lymphoid tissue that is believed to be important in maintaining immunological tolerance, and EV infections have been shown to associate with tolerogenic immune responses, for example, production of IL-10.
30
T A B L E 1 Frequencies of potential confounders in case and control children and associations with the study outcome Maternal microbial infections during pregnancy can affect the fetus in several ways. Viral infections can cross the placental barrier or infect the placenta, which can have severe consequences for the fetus. [31] [32] [33] Infections can also affect the fetus through a local inflammatory response in the placenta or activation of the maternal systemic immune response. 31 For instance, toll-like receptors (TLRs) are an important part of innate immunity against viruses and the type of TLR activated is suggested to depend on the mechanism of replication used by the virus. 34 Maternal exposure to farming has been shown to increase gene expression of certain TLRs in cord blood, 17 and increased expression of some TLR genes at birth has been associated with a reduced risk of atopy in the offspring. 16 There are also some indications that maternal infections during pregnancy might affect the placental microbiome, 35 that may in turn influence the microbial composition of the newborn infant's first intestinal discharge (meconium). 36 Differential activation of innate immunity or changes in the composition of early microbiota might be possible mechanisms behind the findings in our study and offer an interesting field for future research.
The strengths of this study include the prospective study setting, availability of paired serum samples taken during pregnancy and the strict definition of atopic outcome including both IgE sensitization and a clinically relevant atopic disease. Most importantly, we relied on serologically confirmed infections. Many infections, including EV infections, are asymptomatic or cause only mild clinical presentations, but serological assays are able to capture both symptomatic and silent infections. There are only a few previous studies with laboratory-confirmed infections during pregnancy, and to our There are some limitations of our study. First, lack of information on parental history of atopy prevented us from analysing the results with respect to different genetic backgrounds. Therefore, the possibility that atopic mothers are genetically less susceptible to EV infections or that there is another immunological or environmental factor affected by maternal atopy status, cannot be excluded. Secondly, our study population was selected for type 1 diabetes-associated HLA genotypes, which could affect the generalizability of the results.
Although HLA-DQ region has been linked to asthma, the genetic backgrounds of IgE sensitization and atopic diseases are highly polymorphic with no strong association to HLA-DQ region. 39 Therefore, we find it unlikely that the HLA selection would substantially influence our results. Furthermore, the case and control groups were matched for the type 1 diabetes-associated HLA genotypes. It should also be noted that the prevalence of acute EV infections during pregnancy was found to be relatively low, being in line with previous studies. 37, 40 As atopic diseases are common in childhood, it is likely that gestational EV infections are not a major risk-modifying factor in atopy. However, the observational design of the present study makes it difficult to estimate the potential size of this effect on population level reliably. One should also note that even though the specificity of the current EV antibody assay has been well documented, 41 we cannot completely exclude the possibility that in some cases, it could have detected antibodies against other viruses than
EVs. Finally, we have not addressed the mechanisms behind the inverse association between gestational EV infections and atopy, and therefore, it is possible that EVs are merely a surrogate marker for a certain kind of environment mediating the effect observed.
In conclusion, our study suggests that maternal EV infections during pregnancy are inversely associated with atopic disease in the offspring. Other included microbes causing acute or chronic infections lacked this association suggesting that microbes differ in their capability to affect the processes involved in the development of atopy. This stresses the importance of microbe-specific identification of infections when evaluating their role in the pathogenesis of atopy.
Previous research has shown that postnatal infections play a role in the development of atopy, and our study adds to this knowledge by suggesting that microbial exposure already in utero might also be of importance. Thus, addressing the overall effect of gestational and postnatal infections on the development of atopy is an important objective for future studies.
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